scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1005669259 |
P356 | DOI | 10.1007/S10549-007-9507-X |
P698 | PubMed publication ID | 17351746 |
P2093 | author name string | Amit Goyal | |
Elisabeth Le Nestour | |||
Katharine O'Connell | |||
Robert Mansel | |||
Afimoxifene (4-OHT) Breast Pain Research Group | |||
Valérie Masini-Etévé | |||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | (Z)-4-hydroxytamoxifen | Q4689254 |
phase II clinical trial | Q42824440 | ||
P304 | page(s) | 389-397 | |
P577 | publication date | 2007-03-10 | |
P1433 | published in | Breast Cancer Research and Treatment | Q326085 |
P1476 | title | A phase II trial of Afimoxifene (4-hydroxytamoxifen gel) for cyclical mastalgia in premenopausal women | |
P478 | volume | 106 |
Q33914381 | A randomized phase II presurgical trial of transdermal 4-hydroxytamoxifen gel versus oral tamoxifen in women with ductal carcinoma in situ of the breast |
Q41726822 | Addressing barriers to uptake of breast cancer chemoprevention for patients and providers |
Q37014147 | Boron-Based 4-Hydroxytamoxifen Bioisosteres for Treatment of de Novo Tamoxifen Resistant Breast Cancer |
Q35768721 | Boronic prodrug of 4-hydroxytamoxifen is more efficacious than tamoxifen with enhanced bioavailability independent of CYP2D6 status |
Q26825584 | Development of new estrogen receptor-targeting therapeutic agents for tamoxifen-resistant breast cancer |
Q38792320 | Estrogen Receptors and Signaling in Fibroids: Role in Pathobiology and Therapeutic Implications. |
Q37355945 | In vitro human skin permeation of endoxifen: potential for local transdermal therapy for primary prevention and carcinoma in situ of the breast |
Q53280631 | Local transdermal therapy to the breast for breast cancer prevention and DCIS therapy: preclinical and clinical evaluation. |
Q26825692 | Nuclear receptors and their selective pharmacologic modulators |
Q33739214 | Oral low dose and topical tamoxifen for breast cancer prevention: modern approaches for an old drug. |
Q57487446 | Selective Estrogen Receptor Modulators |
Q26739969 | Tamoxifen Resistance: Emerging Molecular Targets |
Search more.